Epothilones as Natural Compounds for Novel Anticancer Drugs Development
- PMID: 37047035
- PMCID: PMC10093981
- DOI: 10.3390/ijms24076063
Epothilones as Natural Compounds for Novel Anticancer Drugs Development
Abstract
Epothilone is a natural 16-membered macrolide cytotoxic compound produced by the metabolism of the cellulose-degrading myxobacterium Sorangium cellulosum. This review summarizes results in the study of epothilones against cancer with preclinical results and clinical studies from 2010-2022. Epothilone have mechanisms of action similar to paclitaxel by inducing tubulin polymerization and apoptosis with low susceptibility to tumor resistance mechanisms. It is active against refractory tumors, being superior to paclitaxel in many respects. Since the discovery of epothilones, several derivatives have been synthesized, and most of them have failed in Phases II and III in clinical trials; however, ixabepilone and utidelone are currently used in clinical practice. There is robust evidence that triple-negative breast cancer (TNBC) treatment improves using ixabepilone plus capecitabine or utidelone in combination with capecitabine. In recent years innovative synthetic strategies resulted in the synthesis of new epothilone derivatives with improved activity against refractory tumors with better activities when compared to ixabepilone or taxol. These compounds together with specific delivery mechanisms could be developed in anti-cancer drugs.
Keywords: anticancer agents; clinical trials; cytotoxicity; epothilone derivates; epothilones; refractory cancer; taxanes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Preclinical discovery of ixabepilone, a highly active antineoplastic agent.Cancer Chemother Pharmacol. 2008 Dec;63(1):157-66. doi: 10.1007/s00280-008-0724-8. Epub 2008 Mar 18. Cancer Chemother Pharmacol. 2008. PMID: 18347795 Review.
-
Development of other microtubule-stabilizer families: the epothilones and their derivatives.Anticancer Drugs. 2014 May;25(5):599-609. doi: 10.1097/CAD.0000000000000071. Anticancer Drugs. 2014. PMID: 24398663 Review.
-
Epothilones in breast cancer: review of clinical experience.Ann Oncol. 2007 Jul;18 Suppl 5:v16-21. doi: 10.1093/annonc/mdm174. Ann Oncol. 2007. PMID: 17656557 Review.
-
Synthesis and Activity of Epothilone D.Curr Drug Targets. 2018;19(15):1866-1870. doi: 10.2174/1389450119666180803122118. Curr Drug Targets. 2018. PMID: 30073925 Review.
-
Discovery and development of the epothilones : a novel class of antineoplastic drugs.Drugs R D. 2008;9(1):1-10. doi: 10.2165/00126839-200809010-00001. Drugs R D. 2008. PMID: 18095749 Free PMC article. Review.
Cited by
-
Synthesis and Evaluation of Thiazolyl-indole-2-carboxamide Derivatives as Potent Multitarget Anticancer Agents.ACS Omega. 2024 Sep 24;9(40):41944-41967. doi: 10.1021/acsomega.4c06889. eCollection 2024 Oct 8. ACS Omega. 2024. PMID: 39398118 Free PMC article.
-
Small-Molecule Mitotic Inhibitors as Anticancer Agents: Discovery, Classification, Mechanisms of Action, and Clinical Trials.Int J Mol Sci. 2025 Apr 1;26(7):3279. doi: 10.3390/ijms26073279. Int J Mol Sci. 2025. PMID: 40244152 Free PMC article. Review.
-
Bioprocessing of Epothilone B from Aspergillus fumigatus under solid state fermentation: Antiproliferative activity, tubulin polymerization and cell cycle analysis.BMC Microbiol. 2024 Jan 30;24(1):43. doi: 10.1186/s12866-024-03184-w. BMC Microbiol. 2024. PMID: 38291363 Free PMC article.
-
Identification of 3-[(4-Acetylphenyl)(4-Phenylthiazol-2-Yl)Amino]Propanoic Acid Derivatives as Promising Scaffolds for the Development of Novel Anticancer Candidates Targeting SIRT2 and EGFR.Pharmaceuticals (Basel). 2025 May 16;18(5):733. doi: 10.3390/ph18050733. Pharmaceuticals (Basel). 2025. PMID: 40430551 Free PMC article.
-
Utidelone suppresses PDAC growth and enhances gemcitabine therapy by inducing immunogenic cell death.iScience. 2025 Apr 23;28(6):112509. doi: 10.1016/j.isci.2025.112509. eCollection 2025 Jun 20. iScience. 2025. PMID: 40530421 Free PMC article.
References
-
- Höfle G.R.H. Epothilone, a Myxobacterial Metabolite with Promising Antitumor Activity. In: Cragg G.M.K.D., Newman D.J., editors. Anticancer Agents from Natural Products. 1st ed. CRC Press; Boca Raton, FL, USA: 2005. pp. 413–450.
-
- Höfle G., Bedorf N., Steinmetz H., Schomburg D., Gerth K., Reichenbach H. Epothilone A and B—Novel 16-Membered Macrolides with Cytotoxic Activity: Isolation, Crystal Structure, and Conformation in Solution. Angew. Chem. Int. Ed. 1996;35:1567–1569. doi: 10.1002/anie.199615671. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical